Page URL:

Consultation on the Human Fertilisation and Embryology Authority and the Human Tissue Authority

2 July 2012
By Earl Howe
Parliamentary Under Secretary of State for Quality, Department of Health
Appeared in BioNews 663
In 2010 British doctor Professor Robert Edwards was awarded a Nobel Prize for his pioneering work in IVF. Together with his colleague Dr Patrick Steptoe he created the technique that means today around five million IVF babies have been born to parents who otherwise may have been left childless. Behind this success story is the less prominent but nevertheless essential narrative of how we regulate the sector.

Standards should never come into question, but it's clear to this Government that NHS administrative costs can be streamlined. Estimates suggest that savings of over £180 million could be delivered by 2015 by reducing the number of NHS bodies, including arm's-length bodies.

And that is why I set out proposals to change responsibility for regulating fertility treatment and human tissue last week. The UK-wide consultation will consider whether the responsibilities of the regulators - the Human Fertilisation and Embryology Authority (HFEA) and Human Tissue Authority (HTA) - should move to the Care Quality Commission (CQC) and the Health Research Authority (HRA).

The HFEA and HTA were established as specialist regulators following the first IVF births and concerns around tissue-retention. In the absence of a broader healthcare regulatory system, they have been well-placed to take on those roles. They have been, and continue to be, well-respected and effective regulators.

But times change. The emergence of the HRA and the developing role of the CQC mean that we have to question if the current range and number of regulators is sustainable.

Over 90 percent of the centres licensed by the HFEA in England are also regulated by, or are in premises regulated by, the CQC. We recognise the value of specialism, but we also need to consider the benefits and economies of scale. At the moment, each of the regulatory bodies has their own independent organisational infrastructures that require support. We must consider whether this is the best use of taxpayers' money.

The consultation sets out options on where HFEA and HTA functions might be transferred to. It also includes the option to retain current structures but deliver further efficiencies.

We have been clear, and will continue to reiterate, that this is about the consideration and rationalisation of who undertakes regulation and not about undermining safeguards and standards, both of which will remain firmly in place. Matters concerning human embryos and human tissue are too important for any other stance to be taken.

The Human Fertilisation and Embryology Act and the Human Tissue Act quite rightly provide the superstructure of prohibitions, definitions, requirements and restrictions put in place by Parliament. These apply, and will continue to do so, regardless of who the regulator is.

The consultation is a significant step in the process towards streamlining health regulation, and we hope that as many people as possible will take part in this important opportunity to shape that process.

24 September 2012 - by Cait McDonagh 
'Quangoing, going, gone', a debate organised by the Progress Educational Trust and the Anne McLaren Memorial Fund highlighted the diverse viewpoints on just what should happen to the Human Fertilisation and Embryology Authority as the government seeks to streamline health regulation...
17 September 2012 - by Peter Thompson 
It's a busy week for the Human Fertilisation and Embryology Authority (HFEA). As we launch our government-commissioned public consultation on mitochondria replacement, we are in the midst of a public debate about who should regulate IVF and embryo research. We will publish our response to the Government's consultation on the HFEA's future later this week. This comment piece gives a taste of what we will be saying....
3 September 2012 - by Henny Braund 
The political debate around the Government's Arm's-Length Body Review has centred on whether any change will deliver greater accountability, financial efficiencies or cuts to services. For Anthony Nolan, a charity that helps provide stem cells for patients who need life-saving transplants, the review is more nuanced...
13 August 2012 - by Antony Starza-Allen 
The UK's regulatory body on the use and storage of human tissue has outlined its position in support of its continued existence amid the Government's review of arm's length bodies...
23 July 2012 - by Walter Merricks 
To many people concerned with donor conception - patients, parents, donors and donor-conceived people - the Government plans to abolish the Human Fertilisation and Embryology Authority (HFEA) sound extremely worrying...
2 July 2012 - by Ayesha Ahmad 
The UK Government has launched a consultation on the future of the Human Fertilisation and Embryology Authority (HFEA) and Human Tissue Authority (HTA) amid proposals to transfer the regulators' functions elsewhere....
2 April 2012 - by Dr Tamara Hirsch 
A recent report claims England's regulator of health and social care, the Care Quality Commission (CQC), is not at present ready to take on the functions of the Human Fertilisation and Embryology Authority (HFEA)...
19 December 2011 - by Sandy Starr 
The Public Bodies Bill - which empowers the UK Government to transfer the functions of the Human Fertilisation and Embryology Authority (HFEA), the country's regulator of fertility treatment and embryo research - has received Royal Assent and has become the Public Bodies Act. This Act represents the realisation in statute of the Coalition Government's longstanding plans for a 'bonfire of the quangos'...
31 October 2011 - by Sandy Starr 
The Public Bodies Bill - which, if passed, will allow the Government to abolish the UK's fertility regulator, the Human Fertilisation and Embryology Authority - has completed its report stage and third reading in the House of Commons...
24 October 2011 - by Walter Merricks 
Perhaps the Government is right to plan to abolish the Human Fertilisation and Embryology Authority (HFEA). The astonishing behaviour of its members at last week's open Authority meeting over compensation for egg and sperm donors will lower its reputation in the eyes of some of its erstwhile supporters. Those who might have manned the barricades to halt the Government's plans may now wonder whether the Care Quality Commission (CQC) – the health and social care regulator set to take over the H...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.